Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Formulation and Evaluation of Maltodextrin Based Doxorubicin HCl Proniosomes


Affiliations
1 JNTU Hyderabad and V. L. College of Pharmacy, Raichur, India
2 Department of Pharmaceutics, V. L. College of Pharmacy, Raichur, India
3 Department of Pharmaceutics, Oxford College of Pharmacy, Bengaluru, India
     

   Subscribe/Renew Journal


Aim of the present research work is to prepare and evaluate maltodextrin based proniosomes loaded with doxorubicin HCl. Proniosomes were prepared by slurry method using molar ratios of nonionic surfactant with cholesterol and keeping drug, maltodextrin and DCP constant. The niosomes were prepared by simple hydration and further evaluated for entrapment efficiency, particle size and shape analysis by optical microscopy, in vitro drug release study, kinetic data analysis and model fitting. Stability study by ICH guides lines. The study revels more stable when stored at 4°C. The formulation FD3, which showed entrapment efficiency of 84.88 ± 0.14 and in vitro release over the period of 36h 95.19± 0.20, was found to be best formulation is span 60. The niosomes shows the Korsemayer Peppas exponential n<0.84 indicate the release mechanism was non Ficknian (anomalous transport) i.e. drug released by erosion followed by diffusion mechanism.

Keywords

Doxorubicin HCl, Proniosomes, Niosomes, Surfactants, Cholesterol.
Subscription Login to verify subscription
User
Notifications
Font Size


  • World Health Organization 2006- Fact sheet, 297.
  • Rohit R. Panchal, H. S. Patange, V. S. Nimkar, M. A. Channawar, B. V. Bakde, A. V. Chandewar. Self Emulsifying Drug Delivery System, A Novel Approach in Drug Delivery: A Review. Research J. Pharm. and Tech 2012; 5(1): 1-7.
  • Derle D.V., Kasliwal N.H., Gandhi P.P., Yeole D.R.. Development, Characterization and Evaluation of Niosomes and Liposomes of Bacitracin Zinc. Research J. Pharm. and Tech 2010;3 (4): 1295-1300.
  • Kaur Prabhjot, Kaur Loveleenpreet. Niosomes used as Targeting Drug Delivery System: A Overview. Asian J. Research Chem 2014; 7(7): 687-692.
  • Karthikeyan D, Pandey VP. Preparation and In-Vitro Characterization of Diclofenac Sodium Niosomes for Ocular Use. Research J. Pharm. and Tech 2009;2 (4): 710-713.
  • Walve JR, Bakliwal SR, Rane BR, Pawar SP. Transfersomes: A surrogated carrier for transdermal drug delivery system. Int J Appl Biol Pharm Technol 2011;2:204-213.
  • Vale CA et al. Construction of enzymosomes: Optimization of coupling parameters. NSTI Nanotech 2006;2:396-407.
  • Kish-Trier E, Hill CP. Structural biology of the proteasome. Annu Rev Biophys 2013;42:29-49.
  • Kaneda Y. Virosomes: Evolution of the liposome as a targeted drug delivery system. Adv Drug Deliv Rev 2000; 43:197-205.
  • Saraf S, Paliwal S, Saraf S. Sphingosomes a novel approach to vesicular drug delivery. Int J Cur Sci Res 2011;1:63-68.
  • González-PA et al. Archaeosomes as carriers for topical delivery of betamethasone dipropionate: In vitro skin permeation study. J Liposome Res 2010;20:269-276.
  • Vijayakumar MR, Sathalia AH, Arun K. Formulation and evaluation of diclofenac potassium ethosomes. Int J Pharm Pharm Sci 2010;2:82-86.
  • Kavitha D, Sowjanya J, Panaganti S. Pharmacosomes: An emerging vesicular system. Int J Pharm Sci Rev Res 2010;5:168-171.
  • Dubey S et al. Niosomes: The ultimate drug carrier. Drug Invent Today 2010; 2:72-77.
  • Wafa Mossa Ramadan, Ajay Pal Singh. Preparation of Acyclovir Loaded Non ionic Surfactant Vesicles (Niosomes) Using Reverse Phase Evaporation Technique. Research J. Pharm. and Tech 2009;2(4):793-795.
  • Srikanth, M Nappinnai, VRM Gupta. Proniosomes: A Novel Drug Carrier System. Research J. Pharm. and Tech 2010;3 (3): 709-711.
  • M.S. Kondawar, K.G. Kamble, M.K. Malusare, J.J. Waghmare, N.D. Shah. Proniosome Based Drug Delivery System for Clotrimazole. Research J. Pharm. and Tech 2011; 4(8): 1284-1287.
  • Mohamed Nasr. In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration. AAPS Pharm Sci Tech 2010;11(1):85-89.
  • Maryam Khatoon et al. Proniosomes derived niosomes: recent advancements in drug delivery and targeting. Drug Delivery 2017;24(2)56–69.
  • Rekha K, Kuldeep V, Aatish V, Girish KY, Sheo DM. Proniosomes: a key to improved drug delivery. J Drug Deli Thera 2014;1:56-65.
  • Tamer M et al. Proniosomal Oral Tablets for Controlled Delivery and Enhanced Pharmacokinetic Properties of Acemetacin. AAPS Pharm Sci Tech 2015;16( 20):375-383.
  • Allen TM, Mehra T, Hansen CB, Chin YC. Stealth liposomes: an improved sustained release system for 1-β-D-arabinofuranosylcytosine. Can Res 1992; 52: 2431-2439.
  • Gabizon A, Catane R, Uziely B, Kaufman B, Safra T, Cohen R et al. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin HCl encapsulated in polyethylene-glycol coated liposomes. Cancer Res 1994;54:987-992.
  • Perrett S, Golding M, Williams WP. A simple method for the preparation of liposomes for pharmaceutical applications: characterization of the liposomes. Pharm Pharmacol 1991; 43:154-161.
  • N. Narasimha Rao, P. Srinivasa Babu. A Dihitha Chowdary, Y. Divya, T. Sri Laksmi, K. Sai Sneha Latha, P. Sirisha. Niosomes: A Vesicular Drug Delivery System. Research J. Pharm. and Tech 2018; 11(8): 3731-3736.
  • N. Madoria, M. Pathodiya, A. Tiwari. Aceclofenac Loaded Vesicles: A Comparative Study between Various Vesicular Systems. Research J. Pharm. and Tech 2012; 5(8): 1130-1138.
  • Y. Prem Kumar, K. Vinod Kumar, V. Sai Kishore. Preparation and Evaluation of Diclofenac Niosomes by Various Techniques. Research J. Pharm. and Tech 2013; 6(10): 1097-1101.
  • Hao Y, Zhao F, Li N, Yang Y, Li K. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 2002; 244: 73-80.
  • The European Agency for the Evaluation of Medicinal Products. Stability testing guidelines: Stability testing of new drug substances and products. London: ICH Technical Coordination, EMEA; 2003. Available from: http://www.emea.eu.int. [Cited on 2009 Dec].
  • Gannu PK, Pogaku R. Nonionic surfactant vesicular systems for effective drug delivery-an overview. Acta Pharma Sinica B 2011;1(4):208–219.

Abstract Views: 181

PDF Views: 0




  • Formulation and Evaluation of Maltodextrin Based Doxorubicin HCl Proniosomes

Abstract Views: 181  |  PDF Views: 0

Authors

Srikanth
JNTU Hyderabad and V. L. College of Pharmacy, Raichur, India
Y. Anand Kumar
Department of Pharmaceutics, V. L. College of Pharmacy, Raichur, India
C. Mallikarjuna Setty
Department of Pharmaceutics, Oxford College of Pharmacy, Bengaluru, India

Abstract


Aim of the present research work is to prepare and evaluate maltodextrin based proniosomes loaded with doxorubicin HCl. Proniosomes were prepared by slurry method using molar ratios of nonionic surfactant with cholesterol and keeping drug, maltodextrin and DCP constant. The niosomes were prepared by simple hydration and further evaluated for entrapment efficiency, particle size and shape analysis by optical microscopy, in vitro drug release study, kinetic data analysis and model fitting. Stability study by ICH guides lines. The study revels more stable when stored at 4°C. The formulation FD3, which showed entrapment efficiency of 84.88 ± 0.14 and in vitro release over the period of 36h 95.19± 0.20, was found to be best formulation is span 60. The niosomes shows the Korsemayer Peppas exponential n<0.84 indicate the release mechanism was non Ficknian (anomalous transport) i.e. drug released by erosion followed by diffusion mechanism.

Keywords


Doxorubicin HCl, Proniosomes, Niosomes, Surfactants, Cholesterol.

References